Between September and October 2013, among 91% of the 2,342 public health facilities contacted, a shocking one in five health facilities reported experiencing a stock out or shortage of ARVs and/or TB medicines within the previous three months. 

Janssen must run a Phase III trial of bedaquiline urgently; More investment in TB drugs and diagnostics urgently needed.

Trade & Industry’s draft IP policy lays foundation to prevent abusive patents from blocking access to affordable medicines.

27 February, MIDRAND – Yesterday, TAC activists picketed at the Africa Intellectual Property (IP) Forum and handed over a memorandum to Rob Davies, Minister of Trade and Industry, before his keynote address. Activists were demanding that the draft IP policy, that will lead to patent law reform, be made public.

Statement by the Treatment Action Campaign, SECTION27, Médecins Sans Frontières and Oxfam.

Statement by the Treatment Action Campaign, the HIV Clinicians Society of Southern Africa, Médecins Sans Frontières, SECTION27 (incorporating the AIDS Law Project), HIV i-Base, Wits Reproductive Health and HIV Institute (WRHI), Jhpiego and the Centre for the AIDS Programme of Research in South Africa (CAPRISA)